stockrowKoninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Revenue
Koninklijke Philips N.V.'s revenue for fiscal 2025 was $20.2B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $20.6B. Over the past ten years it has ranged from $18.8B (fiscal 2022) to $27.1B (fiscal 2016); the current reading is higher than 45% of that period. Koninklijke Philips N.V. ranks 6th of 140 Medical Devices companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $20.2B | 3.47% |
| FY2024 | $19.5B | (0.83%) |
| FY2023 | $19.7B | 4.69% |
| FY2022 | $18.8B | (7.46%) |
| FY2021 | $20.3B | (9.04%) |
| FY2020 | $22.3B | 2.27% |
| FY2019 | $21.8B | 1.96% |
| FY2018 | $21.4B | 6.49% |
| FY2017 | $20.1B | (25.92%) |
| FY2016 | $27.1B | 0.78% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $5.1B | (0.26%) |
| Jun 2026 | $5.1B | 10.92% |
| Mar 2026 | $4.6B | (22.64%) |
| Dec 2025 | $5.9B | 17.49% |
| 37 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | $21.6B |
| BSX Boston Scientific Corporation compare | $21.1B |
| PHG Koninklijke Philips N.V. | $20.6B |
| SNN Smith & Nephew SNATS, Inc. compare | $10.5B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $8.6B |
| EW Edwards Lifesciences Corporation compare | $6.7B |
| STE STERIS plc compare | $6.2B |
| DXCM DexCom, Inc. compare | $5.1B |
| GKOS Glaukos Corporation compare | $690.3M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on PHG
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement